Acute Interstitial Nephritis (AIN) Risk Calculator

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۲۰ • واحد: mg/dL

حداقل ۱ — حداکثر ۳۰۰ • واحد: mg/dL

حداقل ۱ — حداکثر ۱.۰۵

حداقل ۰.۰۱ — حداکثر ۱ • واحد: proportion

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
ain probability
—probability
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–0.2
  • Intermediate Risk0.2–0.5
  • High Risk0.5–1
Direct Clinical Answer

The Acute Interstitial Nephritis (AIN) Risk Calculator calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include creatinine. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Identifies the likelihood of acute interstitial nephritis in at-risk patients undergoing kidney biopsy evaluation. Uses commonly available clinical and laboratory parameters to predict AIN probability.

Clinical Indication

The Acute Interstitial Nephritis (AIN) Risk Calculator is indicated for bedside clinical practice to support Identifies the likelihood of acute interstitial nephritis in at-risk patients undergoing kidney biopsy evaluation. Uses commonly available clinical and laboratory parameters to predict AIN probability.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.

Limitations & Contraindications

eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.

Clinical Pearls & Action Plan

Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI. Guideline pearl: Model showed AUC of 0.73-0.74 in external validation with high negative predictive value (>90%).

Formula & Variables:

Logistic regression model using creatinine, BUN, urine specific gravity, urine protein, and local AIN prevalence to calculate probability of acute interstitial nephritis

Input Parameters

NameTypeRequiredDescription
creatininefloatYesSerum creatinine level(mg/dL)
bunfloatYesBlood urea nitrogen level(mg/dL)
urine_specific_gravityfloatYesUrine specific gravity measurement
urine_dipstick_proteinstringYesUrine dipstick protein level
local_prevalence_ainfloatYesLocal prevalence of AIN among all kidney biopsies. Use 0.23 if unknown.(proportion)

Score Interpretation & Guidance

RangeStageDescription
0–0.2Low RiskLow probability of AIN
0.2–0.5Intermediate RiskIntermediate probability of AIN
0.5–1High RiskHigh probability of AIN

Evidence-Based References (EBM)

  • Moledina DG, Luciano RL, Kukova L, et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol. 2018;13(11):1633-1640.
  • Moledina DG, Wilson FP, Kukova L, et al. Prevalence and outcomes of kidney biopsy in hospitalized patients with acute kidney injury. J Am Soc Nephrol. 2017;28(4):1342-1349.
  • Perazella MA, Moledina DG. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017;12(12):2046-2049.

Related calculators